Glenview Pathology Med Group is categorized under Pathologists in Culver City, CA and active since 1974.
Glenview Pathology Med Group was established in 1974, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pathologists business, which does work in the B2C market, and is classified as a Pathologists, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Margaritte Rose, President at the company’s single location by writing to 10736 Jefferson Boulevard # 609, Culver City, California CA 90230 or by phoning (310) 839-2329. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Glenview Pathology Med Group |
| Contact Person: | Margaritte Rose, President |
| Address: | 10736 Jefferson Boulevard # 609, Culver City, California 90230 |
| Phone Number: | (310) 839-2329 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1974 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathologists |
| SIC Code: | 8011 |
| NAICS Code: | 6219992 |
| Share This Business: |
Glenview Pathology Med Group was started in 1974 to provide professional Pathologists under the SIC code 8011 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Margaritte Rose, President for inquiries that concern Glenview Pathology Med Group by calling the company number (310) 839-2329, as your correspondence is most welcome. Additionally, the physical location of the single location of Glenview Pathology Med Group can be found at the coordinates 34.00301,-118.39401 as well as the street address 10736 Jefferson Boulevard # 609 in Culver City, California 90230.
For its online presence, you may visit Glenview Pathology Med Group’s website at and engage with its social media outlets through on Twitter and on Facebook.